1-8 of 8
Irina Matytsina
Close
Sort by
Journal Articles

A Multiple Ascending Dose Study of Mim8 in Patients with Severe Hemophilia a with or without Factor VIII Inhibitors

Steven R. Lentz, Pratima Chowdary, Francisco Jose Lopez Jaime, Johnny Mahlangu, Irina Matytsina, Anne Louise Nielsen, Jerzy Windyga
Journal: Blood
Blood (2022) 140 (Supplement 1): 2735–2736.
https://doi.org/10.1182/blood-2022-160043
Published: 2022
Journal Articles

Mim8 Clinical Development Program: An Overview of the Frontier Studies

Stephanie Valer Seremetis, Wan Hui Ong Clausen, Irina Matytsina, Susanne Møller Nissen, Karin Wåhlander
Journal: Blood
Blood (2022) 140 (Supplement 1): 5630–5631.
https://doi.org/10.1182/blood-2022-163554
Published: 2022
Journal Articles

A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A

Andreas Tiede, MD, Georg Goldmann, Predrag S Miljić, Lars Korsholm, Irina Matytsina, Paula Persson, Toshko Jelev Lissitchkov, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2491.
https://doi.org/10.1182/blood-2018-99-111269
Published: 2018
Journal Articles

Safety and Efficacy of Turoctocog Alfa in Prevention and on-Demand Treatment of Bleeding Episodes in Patients with Hemophilia A

Dragana Janic, MD PhD, Irina Matytsina, MD, Mudi Misgav, Johannes Oldenburg, Prof, Margareth C Ozelo, Michael Recht, MD PhD, Lars Korsholm, Aleksandar Savic, Elena Santagostino, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3790.
https://doi.org/10.1182/blood.V128.22.3790.3790
Published: 2016
Journal Articles

Successful Use of rFVIII, Turoctocog Alfa, during Orthopedic and Nonorthopedic Surgery in Patients with Severe Hemophilia A

Luigi Solimeno, MD, Steven R. Lentz, MD PhD, Irina Matytsina, MD, Niels Zeuthen, Faraizah Abdul Karim, MD, Elena Santagostino, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2304.
https://doi.org/10.1182/blood.V126.23.2304.2304
Published: 2015
Journal Articles

Changes in Annualized Bleeding Rate over Time and Relationship with Dosing of Turoctocog Alfa during the guardian™ Program

Margareth Ozelo, MD PhD, Dragana Janic, Irina Matytsina, Andrea Landorph, Niels Zeuthan, Elena Santagostino
Journal: Blood
Blood (2014) 124 (21): 2850.
https://doi.org/10.1182/blood.V124.21.2850.2850
Published: 2014
Journal Articles

Factor VIII Dosing and Preventive Efficacy in Obese Patients with Hemophilia (BMI ≥30 kg/m 2 ) – a Post-Hoc Sub-Analysis of the guardian™ Trials

Michael Recht, MD PhD, Steven R. Lentz, MD PhD, Silva Zupancic-Šalek, Irina Matytsina, Andrea Landorph, Trine Saugstrup
Journal: Blood
Blood (2014) 124 (21): 1503.
https://doi.org/10.1182/blood.V124.21.1503.1503
Published: 2014
Journal Articles

Distribution of F8 Gene Mutations in 81 Inhibitor-Free, Severe Hemophilia a Patients with Full Exposure to FVIII

Anna Pavlova, MD PhD, Irina Matytsina, Morio Arai, MD, Johannes Oldenburg, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1527.
https://doi.org/10.1182/blood.V124.21.1527.1527
Published: 2014